Experience

S. Terry Kraus is board certified in Therapeutic Radiology by the American Board of Radiology.

Dr. Kraus received his medical degree from the University of Cincinnati. Upon graduation, he joined the United States Navy and served two years before being honorably discharged at the rank of Lieutenant. Dr. Kraus then completed his internship at The Christ Hospital in Cincinnati and residency in the Department of Radiation Oncology at Shands Teaching Hospital in Gainesville, Florida.

Appointments

Over the last four decades, Dr. Kraus’ appointments have been many. Most recently, he served as Clinical Medical Director for the Department of Radiation Oncology at Tulane Medical Center in New Orleans. He has also held numerous Consulting Staff Physician and Staff Physician positions at the following hospitals:

 

  • LSU Health System, New Orleans, LA
  • Colquitt Regional Hospital, Moultrie, GA

  • Crisp Regional Hospital, Cordele, GA

  • Phoebe Putney Memorial Hospital, Albany, GA

  • HCA Palmyra Hospital, Albany, GA

  • St. Charles Hospital, Luling, LA

  • Thibodeaux Regional Medical Center, Thibodeaux, LA

  • West Jefferson Medical Center (also, Medical Director, Department
    Radiation Oncology, Marrero, LA)

  • Divine Providence Hospital, Williamsport, PA (also, Medical Director,
    Cancer Treatment Center)

Academic Experience

Dr. Kraus is currently serving as Sub-Investigator or Participant in the following Studies:

2012–Retirement from Tulane University Hospital in 2016
Sub-Investigator: Algeta: A Study of Alpharadin in Castration–Resistant (Hormone Refractory) Prostate Cancer Patients with Bone Metastasis
Protocol #Bay 88–80 222/15995

2012–Retirement from Tulane University Hospital in 2016
Sub-Investigator: Algeta: A Study in Alpharadin in Men with Bone Metastasis from Prostate Cancer.
Protocol #Bay 09–00295

April 2014–Retirement from Tulane University Hospital in 2016
Sub-Investigator: A Retreatment Safety Study of Radium 223 Dichloride in Subjects with Castration–Resistant Prostate Cancer with Bone Metastasis Who Received an Initial Course of 6 Doses of Radium 223 Dichloride 50 KBq/K Every 4 Weeks.
Protocol #Bay 16506

April 2014–Retirement from Tulane University Hospital in 2016
Sub-investigator: A Randomized Open–Label Phase IIa Study Evaluating the Efficacy and Safety of Radium 223 Dichloride in Subjects with Castration–Resistant Prostate Cancer with Bone Metastasis Who Received an Initial Course of 6 Doses of Radium–223 Dichloride 50 KBq/Kilogram Every 4 Weeks.
Protocol #Bay 16506

April 2014–Retirement from Tulane University Hospital in 2016
Sub-Investigator: A Phase 3 Randomized, Double-Blind, Placebo Controlled Trial of Radium 223 Dichloride in Combination with Abiraterone Acetate and Prednisone/Prednisolone in the Treatment of Asymptomatic or Mildly Symptomatic Chemotherapy–Naïve Subjects with Bone Predominate Metastatic Castration–Resistant Prostate Cancer (CRPC)
Protocol #Bay 15396

April 2014-Retirement from Tulane University Hospital in 2016
Participant: A Phase 3 Trial of Accelerated Whole Breast Radiation with Hypo-Fractionation plus Contrast Current Boost versus Standard Whole Breast Radiation Plus Sequential Boost for Early Stage Breast Cancer.
RTOG 1005

April 2014 –Retirement from Tulane University Hospital in 2016
Participant: A Randomized Phase 3 Trial of Cisplatin and Tumor Volume Directed Volume Directed Radiation Followed by Carboplatin and Paclitaxel Versus Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma.
GOG O258

April 2014–Retirement from Tulane University Hospital in 2016
Participant: A Phase 3 Trial of Adjuvant Chemotherapy Following Chemoradiation As Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone.
GOG O274

April 2014–Retirement from Tulane University Hospital in 2016
Participant: A Phase 3 Clinical Trial Comparing Trastuzumab Given, Currently with Radiation Therapy and Radiation Therapy Alone for Women with Her 2 Positive Ductal Carcinoma In Situ Resected by Lumpectomy.
NSABP B–43

April 2014-Retirement from Tulane University Hospital in 2016
Participant: A Phase 3 Trial Evaluating Both Locked-In Abdomen and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma.
RTOG 0848

April 2014-Retirement from Tulane University Hospital in 2016
Participant: A Phase 3 Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally–Advanced Resected Head and Neck Cancer.
RTOG 0920

April 2014-Retirement from Tulane University Hospital in 2016
Participant: A Phase 3 Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide.
CALGB 30610/RTOG 0538

2010-Retirement from Tulane University Hospital in 2016
Participant: Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive Disease Small Cell Lung Cancer.
RTOG 0937

2010-Retirement from Tulane University Hospital in 2016
Participant: A Phase 3 Trial of Short-Term Androgen Deprivation with Pelvic Node or Prostate Bed Only Radiation (SPPORT) and Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy.
RTOG 0534

Dr. Kraus is currently involved in a variety of roles with these organizations:

2014–Present
Participant: GI/Pancreas Cancer Conference, Tulane Cancer Center
Participant: Urology Cancer Conference, Tulane Cancer Center
Participant: Thyroid Cancer Conference/Endocrine Conference, Tulane Cancer Center

2012–Present
Executive Leadership Council of the American Cancer Society

2011–Present
Greater New Orleans Coalition on Cancer Health Care Disparities
Participant: Lung Cancer Conference, Tulane Cancer Center

2010–Present
Investigator via Group Membership, Tulane Office of Clinical Research Studies
National Cancer Institute, Participant of Clinical Research Studies
National Adjuvant Breast and Bowel Project (NASBP)
Radiation Therapy Oncology Group (RTOG)
Gynecology Oncology Group (GOG)
Southwestern Oncology Group (SWOG)
Co-moderator/participant: Tulane Head and Neck Cancer Disposition Conference
Participant:  Veterans Administration Hospital of New Orleans Cancer Conference
Participant: Breast Cancer Conference, Tulane Cancer Center

1978–Present
Member: American Society of Clinical Oncology

1976–Present
Member: American Society of Radiation Oncology

Invited Appointments/Honors

2011–2014
Quality Control Coordinator for Tulane Cancer Registry

2013
Lecture to Public, “The Role of Radiation Therapy in the Management of Prostate Cancer”

2012
Development of Physician Council for American Cancer Society

2010
Honoree, Physician of the Year Albany, GA
Honoree, Civil Rights Movement for Voter Registration

2009
Honoree, Georgia Cancer Coalition for “Dedication and Commitment to Community Health”

2004–2009
Moderator: Tumor Board Phoebe Putney Memorial Hospital, Albany, GA

2003–2009
Chairman: Cancer Committee Phoebe Putney Memorial Hospital, Albany, GA

1978–2009
Chairman: Ethics Committee, West Jefferson Medical Center, Marrero, LA

1978–2003
Moderator: Tumor Board, West Jefferson Medical Center, Marrero, LA

Publications

Dr. Kraus is co-author of the following publications:

Kelly AG, Rosas-Uribe, Kraus ST. Orbital Lymphomas and Pseudolymphomas: A Clinicopathologic Study of Eleven Cases. Am J Clin Pathol.1977 Sep:68(3):377-86

Bourgeois III, DJ, Kraus S, Maaloaf BN, Sartor O. Radiation for Bone Metastases. Current Opinion in Supportive Care and Palliative Care. 2011; 5:227-232

Dr. Terry Kraus
Oncology Consulting Services, LLC

(504) 717-3237

111 Veterans Memorial Blvd.
Suite 403
Metairie, LA 70005

Oncology Consulting Services